Skip to main content

Sulfasalazine Enteric-Coated and Immediate-Release Tablets

Last Updated: October 25, 2022
Status: Current

Products Affected - Description
    • Sulfasalazine tablet, Teva, 500 mg, bottle, 100 count, NDC 00591-0796-01
    • Sulfasalazine tablet, Teva, 500 mg, bottle, 1000 count, NDC 00591-0796-10
Reason for the Shortage
    • Viatris has coated and noncoated tablets available.
    • Teva did not provide a reason for the shortage.
    • Pfizer has Azulfidine and Azulfidine Entabs available.
Available Products
    • Azulfidine Entabs coated tablet, Pfizer, 500 mg, bottle, 100 count, NDC 00013-0102-50
    • Azulfidine Entabs coated tablet, Pfizer, 500 mg, bottle, 300 count, NDC 00013-0102-60
    • Sulfasalazine coated tablet, Greenstone (Viatris), 500 mg, bottle, 100 count, NDC 59762-0104-05
    • Sulfasalazine coated tablet, Greenstone (Viatris), 500 mg, bottle, 300 count, NDC 59762-0104-06
    • Azulfidine tablet, Pfizer, 500 mg, bottle, 100 count, NDC 00013-0101-10
    • Azulfidine tablet, Pfizer, 500 mg, bottle, 300 count, NDC 00013-0101-30
    • Sulfasalazine tablet, Greenstone (Viatris), 500 mg, bottle, 100 count, NDC 59762-5000-05
    • Sulfasalazine tablet, Greenstone (Viatris), 500 mg, bottle, 300 count, NDC 59762-5000-06
    • Sulfasalazine tablet, Teva, 500 mg, bottle, 500 count, NDC 00591-0796-05

Estimated Resupply Dates

    • Teva has sulfasalazine immediate-release 500 mg tablets in 100 count and 1,000 count bottles on back order and the company estimates a release date of mid-November 2022.

Updated

Updated October 25, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 8, 2020 by Rachael Freeman, PharmD, BCPS. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.